Title – Potential of screening for fracture risk – what we are learning from recent controlled trials
Speaker – Professor Eugene McCloskey, Academic Unit of Bone Metabolism, Department of Oncology and Metabolism
Venue – Lecture Theatre 3, F Floor, The Medical School
Date – Friday 19 October 2018
Time – 1.00-2.00 pm
Eugene McCloskey is Professor in Adult Bone Diseases in the Academic Unit of Bone Metabolism and Mellanby Centre for Bone Research at the University of Sheffield. In addition to clinical work, he is also the past president of the Bone Research Society and current Director of the MRC ARUK Centre for Integrated research in Musculoskeletal Ageing (CIMA). He has published over 390 peer-reviewed publications, book chapters and reviews and is an acknowledged authority in the fields of vertebral fracture definition, osteoporosis epidemiology and treatment, fracture risk assessment and bone health in cancer. He contributed to the development of the FRAX tool and the subsequent guideline from the National Osteoporosis Guideline Group. He is on a number of editorial boards and is a member of committees within organisations including the Boards of IOF and ESCEO. In 2016, he was awarded the IOF Medal of Achievement, presented annually to recognise an individual researcher who has significantly advanced the field of osteoporosis through original and outstanding scientific contributions. In 2018, he was honoured with the ECTS Philippe Bordier Award for a significant clinical contribution to the field of bone and calcified tissue.
The recent SCOOP trial was led by Professor McCloskey. There have been further trials in this area which he will discuss. Take as a whole, these studies may provide a basis for altering our approach to case finding in osteoporosis.